[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,171,363
  • Shares Outstanding, K 319,023
  • Annual Sales, $ 3,019 M
  • Annual Income, $ 72,060 K
  • EBIT $ 434 M
  • EBITDA $ 680 M
  • 60-Month Beta 1.30
  • Price/Sales 1.72
  • Price/Cash Flow 10.38
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 48.38% (-4.49%)
  • Historical Volatility 41.23%
  • IV Percentile 6%
  • IV Rank 26.47%
  • IV High 175.93% on 03/30/26
  • IV Low 2.47% on 09/09/25
  • Expected Move (DTE 26) 1.31 (8.08%)
  • Put/Call Vol Ratio 2.03
  • Today's Volume 91
  • Volume Avg (30-Day) 130
  • Put/Call OI Ratio 0.51
  • Today's Open Interest 3,450
  • Open Int (30-Day) 2,818
  • Expected Range 14.90 to 17.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.24
  • Number of Estimates 1
  • High Estimate $0.24
  • Low Estimate $0.24
  • Prior Year $0.23
  • Growth Rate Est. (year over year) +4.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.76 +37.84%
on 05/19/26
16.61 -2.41%
on 06/18/26
+4.29 (+35.99%)
since 05/18/26
3-Month
11.71 +38.43%
on 03/24/26
16.61 -2.41%
on 06/18/26
+3.82 (+30.83%)
since 03/18/26
52-Week
7.66 +111.48%
on 08/01/25
16.61 -2.41%
on 06/18/26
+8.27 (+104.16%)
since 06/18/25

Most Recent Stories

More News
1 Small-Cap Stock for Long-Term Investors and 2 We Find Risky

1 Small-Cap Stock for Long-Term Investors and 2 We Find Risky

NSIT : 108.44 (+1.38%)
TTD : 18.51 (+1.93%)
AMRX : 16.21 (-0.43%)
Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals

Amneal's Commitment Helps Support a Reliable Supply of Essential Medicines for Uninsured and Underserved Patients Nationwide

AMRX : 16.21 (-0.43%)
3 Russell 2000 Stocks with Open Questions

3 Russell 2000 Stocks with Open Questions

RXO : 25.39 (+2.30%)
TDUP : 6.01 (+12.76%)
AMRX : 16.21 (-0.43%)
Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

Phase 4 ELEVATE-PD interim data from the entire study population (n=214) continue to show clinically meaningful, consistent benefits of CREXONT across all prior treatment groups Substantial increases...

AMRX : 16.21 (-0.43%)
Why Amneal (AMRX) Stock Is Trading Up Today

Why Amneal (AMRX) Stock Is Trading Up Today

AMRX : 16.21 (-0.43%)
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

Ready-to-use romidepsin formulation; offers a more convenient alternative to lyophilized powder requiring reconstitution Competitive Generic Therapy approval provides 180 days of market exclusivity...

AMRX : 16.21 (-0.43%)
3 Profitable Stocks with Open Questions

3 Profitable Stocks with Open Questions

USNA : 18.88 (+2.61%)
WST : 327.95 (+1.35%)
AMRX : 16.21 (-0.43%)
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

BRIDGEWATER, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), today announced that Chirag Patel, Co-Chief Executive and President,...

AMRX : 16.21 (-0.43%)
Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks

Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks

AMRX : 16.21 (-0.43%)
2 Reasons AMRX is Risky and 1 Stock to Buy Instead

2 Reasons AMRX is Risky and 1 Stock to Buy Instead

AMRX : 16.21 (-0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 17.52
2nd Resistance Point 17.06
1st Resistance Point 16.64
Last Price 16.21
1st Support Level 15.76
2nd Support Level 15.30
3rd Support Level 14.88

See More

52-Week High 16.61
Last Price 16.21
Fibonacci 61.8% 13.19
Fibonacci 50% 12.14
Fibonacci 38.2% 11.08
52-Week Low 7.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.